Trial intelligence / Profile preview

Shuxinding sulfate for ventricular premature beats and non-sustained VT

CTR20150060Phase 2Suspended

Sponsor
Shanghai Institute of Materia Medica
Start
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of shuxinding sulfate in Premature ventricular complexes (PVC), ventricular tachycardia (VT), sponsored by Shanghai Institute of Materia Medica. Started Feb 2015; status: suspended.

02

Drugs

shuxinding sulfate
03

Conditions

Premature ventricular complexes (PVC)ventricular tachycardia (VT)

Beyond the preview

Go deeper on CTR20150060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call